Stocks & Investing
Stocks and Investing
Stocks and Investing
Thu, September 26, 2024
[ Thu, Sep 26th 2024
] - WOPRAI
[ Thu, Sep 26th 2024
] - WOPRAI
[ Thu, Sep 26th 2024
] - WOPRAI
[ Thu, Sep 26th 2024
] - WOPRAI
[ Thu, Sep 26th 2024
] - WOPRAI
[ Thu, Sep 26th 2024
] - WOPRAI
[ Thu, Sep 26th 2024
] - WOPRAI
[ Thu, Sep 26th 2024
] - WOPRAI
[ Thu, Sep 26th 2024
] - WOPRAI
[ Thu, Sep 26th 2024
] - WOPRAI
[ Thu, Sep 26th 2024
] - WOPRAI
[ Thu, Sep 26th 2024
] - WOPRAI
[ Thu, Sep 26th 2024
] - WOPRAI
[ Thu, Sep 26th 2024
] - WOPRAI
[ Thu, Sep 26th 2024
] - WOPRAI
[ Thu, Sep 26th 2024
] - WOPRAI
[ Thu, Sep 26th 2024
] - WOPRAI
[ Thu, Sep 26th 2024
] - WOPRAI
[ Thu, Sep 26th 2024
] - WOPRAI
[ Thu, Sep 26th 2024
] - WOPRAI
[ Thu, Sep 26th 2024
] - WOPRAI
[ Thu, Sep 26th 2024
] - WOPRAI
[ Thu, Sep 26th 2024
] - WOPRAI
[ Thu, Sep 26th 2024
] - WOPRAI
[ Thu, Sep 26th 2024
] - WOPRAI
[ Thu, Sep 26th 2024
] - WOPRAI
[ Thu, Sep 26th 2024
] - WOPRAI
[ Thu, Sep 26th 2024
] - WOPRAI
[ Thu, Sep 26th 2024
] - WOPRAI
[ Thu, Sep 26th 2024
] - WOPRAI
David Nierengarten Reiterated (ANAB) at Buy and Held Target at $42 on, Sep 26th, 2024
David Nierengarten of Wedbush, Reiterated "AnaptysBio, Inc." (ANAB) at Buy and Held Target at $42 on, Sep 26th, 2024.
David has made no other calls on ANAB in the last 4 months.
There are 3 other peers that have a rating on ANAB. Out of the 3 peers that are also analyzing ANAB, 1 agrees with David's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- John Lee of "Truist Securities" Maintained at Hold with Increased Target to $30 on, Thursday, August 15th, 2024
These are the ratings of the 2 analyists that currently disagree with David
- Emily Bodnar of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $55 on, Wednesday, August 14th, 2024
- Anupam Rama of "JP Morgan" Maintained at Buy with Increased Target to $75 on, Wednesday, August 7th, 2024
